Avanza Fonder
RPRX icon

Avanza Fonder’s Royalty Pharma RPRX Stock Holding History

Avanza Fonder’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$96.2K Hold
1,649
– – ﹤0.01% 432
2026
Q2 		$92.5K Hold
1,649
– – ﹤0.01% 433
2026
Q1 		$79.1K Buy
+1,649
New +$72.2K ﹤0.01% 466

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
New South Capital Management
New South Capital Management Memphis, Tennessee $1.53B AUM 36.31% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Avanza Fonder's RPRX Position: Q3 2026 in Review

Avanza Fonder held its Royalty Pharma (RPRX) position steady in Q3 2026 at 1,649 shares worth $96.2K. The position accounts for ﹤0.01% of the portfolio, ranked #432.

Avanza Fonder first reported a position in RPRX in Q1 2026 and has held it in 3 quarters since. 347 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Avanza Fonder held 1,649 shares of Royalty Pharma worth $96.2K as of Q3 2026.
  • Avanza Fonder left its Royalty Pharma share count unchanged in Q3 2026.
  • Royalty Pharma made up ﹤0.01% of Avanza Fonder's portfolio in Q3 2026, its #432 holding.
  • Avanza Fonder first reported a position in Royalty Pharma in Q1 2026 and has held it in 3 quarters since.
  • 347 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Avanza Fonder's 13F filing for Q3 2026, filed 13 Oct 2026.